{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:07:18Z","timestamp":1790690838592,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","obstetanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Obstetric Anesthesia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijoa.2021.103207","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:13:02Z","timestamp":1626894782000},"page":"103207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Refractory uterine atony: still a problem after all these years"],"prefix":"10.1016","volume":"48","author":[{"given":"M.","family":"Balki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijoa.2021.103207_b0005","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2008.01859.x","article-title":"Prevalence and risk factors of severe obstetric haemorrhage","volume":"115","author":"Al-Zirqi","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ijoa.2021.103207_b0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/aogs.13542","article-title":"Women receiving massive transfusion due to postpartum hemorrhage: A comparison over time between two nationwide cohort studies","volume":"98","author":"Ramler","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ijoa.2021.103207_b0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12884-018-1829-7","article-title":"Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial","volume":"18","author":"Huque","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ijoa.2021.103207_b0025","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1213\/ANE.0000000000004424","article-title":"Trends in postpartum hemorrhage in the United States from 2010 to 2014","volume":"130","author":"Reale","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1701-2163(15)30680-0","article-title":"Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010","volume":"36","author":"Mehrabadi","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ijoa.2021.103207_b0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejogrb.2020.12.021","article-title":"Major obstetric haemorrhage: Incidence, management and quality of care in Irish maternity units","volume":"257","author":"Greene","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijoa.2021.103207_b0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/bja\/aeu150","article-title":"Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery","volume":"113","author":"Butwick","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0045","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ajog.2005.07.077","article-title":"The MFMU Cesarean Registry: uterine atony after primary cesarean delivery","volume":"193","author":"Rouse","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318202c845","article-title":"Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity","volume":"117","author":"Driessen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0055","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1055\/s-0040-1721671","article-title":"Association between receipt of intrapartum magnesium sulfate and postpartum hemorrhage","volume":"11","author":"Miller","year":"2021","journal-title":"AJP Rep"},{"key":"10.1016\/j.ijoa.2021.103207_b0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2013.03.011","article-title":"Risk factors for uterine atony\/postpartum hemorrhage requiring treatment after vaginal delivery","volume":"209","author":"Wetta","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0065","first-page":"155","article-title":"National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage","volume":"126","author":"Main","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0070","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet Gynecol. 2017;130:e168-e86. https:\/\/doi.org\/10.1097\/aog.0000000000002351.","DOI":"10.1097\/AOG.0000000000002351"},{"key":"10.1016\/j.ijoa.2021.103207_b0075","doi-asserted-by":"crossref","unstructured":"Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage: Green-top guideline no. 52. BJOG. 2017;124:e106-e49. https:\/\/doi.org\/10.1111\/1471-0528.14178.","DOI":"10.1111\/1471-0528.14178"},{"key":"10.1016\/j.ijoa.2021.103207_b0080","unstructured":"The Joint Commission. R3 Report: Provision of care, treatment, and service standards for maternal safety. Issue 24, August 21, 2019. https:\/\/www.jointcommission.org\/-\/media\/tjc\/documents\/standards\/r3-reports\/r3_24_maternal_safety_hap_9_6_19_final1.pdf. Accessed March 13 2021."},{"key":"10.1016\/j.ijoa.2021.103207_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0b013e3182941c78","article-title":"Clinical validation of risk stratification criteria for peripartum hemorrhage","volume":"122","author":"Dilla","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ijoa.2021.103207_b0095","first-page":"701","article-title":"Pharmacokinetics of oxytocin in the human subject","volume":"56","author":"Leake","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000142709.04450.bd","article-title":"Oxytocin requirements at elective cesarean delivery: a dose-finding study","volume":"104","author":"Carvalho","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12630-010-9297-1","volume":"57","author":"George","year":"2010","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1213\/ANE.0000000000000781","article-title":"The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study","volume":"121","author":"Lavoie","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/bja\/aeq004","article-title":"Minimum effective bolus dose of oxytocin during elective Caesarean delivery","volume":"104","author":"Butwick","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1213\/00000539-199704000-00010","article-title":"Intravenous oxytocin in patients undergoing elective cesarean section","volume":"84","author":"Sarna","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/anae.15322","article-title":"Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity","volume":"76","author":"Peska","year":"2021","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2021.103207_b0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/anae.14757","article-title":"International consensus statement on the use of uterotonic agents during caesarean section","volume":"74","author":"Heesen","year":"2019","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2021.103207_b0135","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1213\/ANE.0b013e3181f8930a","article-title":"Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial","volume":"111","author":"King","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0140","doi-asserted-by":"crossref","unstructured":"Sheehan SR, Montgomery AA, Carey M, et al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343:d4661. https:\/\/doi.org\/10.1136\/bmj.d4661.","DOI":"10.1136\/bmj.d4661"},{"key":"10.1016\/j.ijoa.2021.103207_b0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2008.09.004","article-title":"A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section\u2013pilot study. ISRCTN 40302163","volume":"142","author":"Murphy","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijoa.2021.103207_b0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1213\/ANE.0000000000001658","article-title":"Effect of a high-rate versus a low-rate oxytocin infusion for maintaining uterine contractility during elective cesarean delivery: a prospective randomized clinical trial","volume":"124","author":"Duffield","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12884-019-2692-x","article-title":"The ED(50) and ED(95) of oxytocin infusion rate for maintaining uterine tone during elective caesarean delivery: a dose-finding study","volume":"20","author":"Qian","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ijoa.2021.103207_b0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/ALN.0b013e318297d347","article-title":"Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro","volume":"119","author":"Balki","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijoa.2021.103207_b0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.AOG.0000191529.52596.c0","article-title":"Minimum oxytocin dose requirement after cesarean delivery for labor arrest","volume":"107","author":"Balki","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0170","first-page":"386","article-title":"Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial","volume":"98","author":"Munn","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijoa.2016.10.003","article-title":"The role of carbetocin in the prevention and management of postpartum haemorrhage","volume":"28","author":"Meshykhi","year":"2016","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0180","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/j.jogc.2018.09.024","article-title":"Society of Obstetricans and Gynaecologists of Canada. No. 235-Active management of the third stage of labour: Prevention and treatment of postpartum hemorrhage","volume":"40","author":"Leduc","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ijoa.2021.103207_b0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s12630-013-0082-9","article-title":"Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective doseLa carb\u00e9tocine lors d\u2019un accouchement par c\u00e9sarienne programm\u00e9: une \u00e9tude d\u2019attribution s\u00e9quentielle afin de d\u00e9terminer la dose efficace minimale","volume":"61","author":"Khan","year":"2014","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0190","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s12630-013-0028-2","article-title":"Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2La carb\u00e9tocine lors d\u2019un accouchement par c\u00e9sarienne programm\u00e9: une \u00e9tude randomis\u00e9e contr\u00f4l\u00e9e pour d\u00e9terminer la dose efficace, 2e partie","volume":"60","author":"Anandakrishnan","year":"2013","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12630-012-9728-2","article-title":"Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective doseCarb\u00e9tocine et c\u00e9sarienne programm\u00e9e: \u00e9tude randomis\u00e9e contr\u00f4l\u00e9e pour la d\u00e9termination de la dose efficace","volume":"59","author":"Cordovani","year":"2012","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/anae.14480","article-title":"Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 \u03bcg and 100 \u03bcg","volume":"74","author":"Tabl","year":"2019","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2021.103207_b0205","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12630-015-0375-2","volume":"62","author":"Nguyen-Lu","year":"2015","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0000000000000940","article-title":"In vitro comparative effect of carbetocin and oxytocin in pregnant human myometrium with and without oxytocin pretreatment","volume":"124","author":"Cole","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijoa.2021.103207_b0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/anae.14944","article-title":"Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women","volume":"75","author":"Drew","year":"2020","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ijoa.2021.103207_b0220","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s12630-020-01615-6","article-title":"The effect of morbid obesity or advanced maternal age on oxytocin-induced myometrial contractions: an in vitro studyEffet de l\u2019ob\u00e9sit\u00e9 morbide ou de l\u2019\u00e2ge maternel avanc\u00e9 sur les contractions myom\u00e9triales induites par l\u2019oxytocine: une \u00e9tude in vitro","volume":"67","author":"Luca","year":"2020","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0225","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1805489","article-title":"Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth","volume":"379","author":"Widmer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijoa.2021.103207_b0230","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1080\/14767058.2019.1664463","article-title":"Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials","volume":"34","author":"Kalafat","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ijoa.2021.103207_b0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijoa.2019.06.007","article-title":"Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials","volume":"40","author":"Onwochei","year":"2019","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijgo.2006.05.032","article-title":"Hemodynamic effects of oxytocin during cesarean delivery","volume":"95","author":"Langesaeter","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijoa.2021.103207_b0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/bja\/aen071","article-title":"Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section","volume":"100","author":"Svanstr\u00f6m","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0250","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/endo.140.3.6546","article-title":"Human vascular endothelial cells express oxytocin receptors","volume":"140","author":"Thibonnier","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijoa.2021.103207_b0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/bja\/ael302","article-title":"Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section","volume":"98","author":"Thomas","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0260","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1471-0528.2011.03022.x","article-title":"Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial","volume":"118","author":"Moertl","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ijoa.2021.103207_b0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijoa.2010.10.004","article-title":"Haemodynamic effects of oxytocin in women with severe preeclampsia","volume":"20","author":"Langes\u00e6ter","year":"2011","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0270","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00003495-199856040-00002","article-title":"Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology","volume":"56","author":"N.J.A. de Groot","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ijoa.2021.103207_b0275","unstructured":"Methergine (package insert). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/006035s078lbl.pdf; 2012. Accessed February 28, 2021."},{"key":"10.1016\/j.ijoa.2021.103207_b0280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0301-2115(95)02530-8","article-title":"Instability of (methyl)ergometrine in tropical climates: an overview","volume":"69","author":"Hogerzeil","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijoa.2021.103207_b0285","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1213\/ANE.0000000000001765","article-title":"A role for adrenergic receptors in the uterotonic effects of ergometrine in isolated human term nonlaboring myometrium","volume":"124","author":"Fanning","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0290","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12630-014-0190-1","volume":"61","author":"Balki","year":"2014","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.anclin.2017.01.007","article-title":"Uterotonic medications: oxytocin, methylergonovine, carboprost, misoprostol","volume":"35","author":"Vallera","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.ijoa.2021.103207_b0300","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1521-6934(03)00043-9","article-title":"Pharmacokinetics of prostaglandins","volume":"17","author":"Bygdeman","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0305","unstructured":"Hemabate: carboprost tromethamine injection, USP [package insert] https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/017989s019lbl.pdf; 2013. Accessed March 6, 2021."},{"key":"10.1016\/j.ijoa.2021.103207_b0310","doi-asserted-by":"crossref","first-page":"102962","DOI":"10.1016\/j.ijoa.2021.102962","article-title":"Generalised tonic-clonic seizures after intramyometrial carboprost injection","volume":"46","author":"Jha","year":"2021","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0315","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0959-289X(94)90213-5","article-title":"Severe bronchospasm and hypotension after 15-methyl prostaglandin F(2alpha) in atonic post partum haemorrhage","volume":"3","author":"O'Leary","year":"1994","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.ijoa.2021.103207_b0320","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.ijgo.2007.09.012","article-title":"Prevention of postpartum hemorrhage with misoprostol","volume":"99","author":"Alfirevic","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijoa.2021.103207_b0325","unstructured":"Cytotec misoprostil tablets [package insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/019268s041lbl.pdf; 2009. Accessed March 7, 2021."},{"key":"10.1016\/j.ijoa.2021.103207_b0330","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ijoa.2021.103207_b0335","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2003.09.011","article-title":"Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery","volume":"113","author":"Chong","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijoa.2021.103207_b0340","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ijoa.2021.103207_b0345","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: Drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0350","first-page":"968","article-title":"Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor","volume":"101","author":"Khan","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0355","doi-asserted-by":"crossref","unstructured":"Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014;2014:CD003249. https:\/\/doi.org\/10.1002\/14651858.CD003249.pub3.","DOI":"10.1002\/14651858.CD003249.pub3"},{"key":"10.1016\/j.ijoa.2021.103207_b0360","first-page":"S202","article-title":"Treatment of postpartum hemorrhage with misoprostol","volume":"99","author":"Blum","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijoa.2021.103207_b0365","doi-asserted-by":"crossref","unstructured":"Hofmeyr GJ, G\u00fclmezoglu AM, Novikova N, Lawrie TA. Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database Syst Rev. 2013:CD008982. https:\/\/doi.org\/10.1002\/14651858.CD008982.pub2.","DOI":"10.1002\/14651858.CD008982.pub2"},{"key":"10.1016\/j.ijoa.2021.103207_b0370","doi-asserted-by":"crossref","unstructured":"Gallos ID, Papadopoulou A, Man R, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12:CD011689. https:\/\/doi.org\/10.1002\/14651858.CD011689.pub3.","DOI":"10.1002\/14651858.CD011689.pub3"},{"key":"10.1016\/j.ijoa.2021.103207_b0375","doi-asserted-by":"crossref","unstructured":"Quibel T, Ghout I, Goffinet F, et al. Active management of the third stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage: A randomized controlled trial. Obstet Gynecol. 2016;128:805-811. https:\/\/doi.org\/10.1097\/aog.0000000000001626.","DOI":"10.1097\/AOG.0000000000001626"},{"key":"10.1016\/j.ijoa.2021.103207_b0380","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1471-0528.2007.01658.x","article-title":"Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest","volume":"115","author":"Balki","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ijoa.2021.103207_b0385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/AOG.0000000000004288","article-title":"Prophylactic administration of uterotonics to prevent postpartum hemorrhage in women undergoing cesarean delivery for arrest of labor: A randomized controlled trial","volume":"137","author":"Balki","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0390","doi-asserted-by":"crossref","first-page":"76.e1","DOI":"10.1016\/j.ajog.2015.02.023","article-title":"Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines","volume":"213","author":"Dahlke","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00404-013-3016-4","article-title":"Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines","volume":"289","author":"Bohlmann","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijoa.2021.103207_b0400","doi-asserted-by":"crossref","first-page":"e001466","DOI":"10.1136\/bmjgh-2019-001466","article-title":"WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one?","volume":"4","author":"Vogel","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijoa.2021.103207_b0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ALN.0000000000000682","article-title":"A randomized, double-blinded trial of a \u201crule of threes\u201d algorithm versus continuous infusion of oxytocin during elective cesarean delivery","volume":"123","author":"Kovacheva","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijoa.2021.103207_b0410","unstructured":"Likis FE, Sathe NA, Morgans AK, et al. AHRQ Comparative Effectiveness Reviews: Management of postpartum hemorrhage. https:\/\/www-ncbi-nlm-nih-gov.proxy.lib.uiowa.edu\/books\/NBK294465\/; 2015. Accessed March 7, 2021."},{"key":"10.1016\/j.ijoa.2021.103207_b0415","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1213\/ANE.0000000000000398","article-title":"Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007\u20132011","volume":"119","author":"Bateman","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ijoa.2021.103207_b0420","doi-asserted-by":"crossref","unstructured":"Parry Smith WR, Papadopoulou A, Thomas E, et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11:CD012754. https:\/\/doi.org\/10.1002\/14651858.CD012754.pub2.","DOI":"10.1002\/14651858.CD012754.pub2"},{"key":"10.1016\/j.ijoa.2021.103207_b0425","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2015.01.008","article-title":"Second-line uterotonics and the risk of hemorrhage-related morbidity","volume":"212","author":"Butwick","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0430","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0140-6736(10)60348-0","article-title":"Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial","volume":"375","author":"Widmer","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijoa.2021.103207_b0435","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(09)61923-1","article-title":"Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial","volume":"375","author":"Blum","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijoa.2021.103207_b0440","doi-asserted-by":"crossref","first-page":"293.e1","DOI":"10.1016\/j.ajog.2019.11.1287","article-title":"Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis","volume":"222","author":"Suarez","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ijoa.2021.103207_b0445","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/aogs.12077","article-title":"Uterine compression sutures for postpartum hemorrhage: an overview","volume":"92","author":"Matsubara","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ijoa.2021.103207_b0450","first-page":"104","article-title":"Constructing a novel 'uterine sandwich' with simultaneous intrauterine balloon tamponade and uterine compression sutures to manage postpartum bleeding","volume":"80","author":"Wong","year":"2021","journal-title":"Hawaii J Health Soc Welf"},{"key":"10.1016\/j.ijoa.2021.103207_b0455","doi-asserted-by":"crossref","unstructured":"D'Alton ME, Rood KM, Smid MC, et al. Intrauterine vacuum-induced hemorrhage-control device for rapid treatment of postpartum hemorrhage. Obstet Gynecol. 2020;136:882-891. https:\/\/doi.org\/10.1097\/aog.0000000000004138.","DOI":"10.1097\/AOG.0000000000004138"},{"key":"10.1016\/j.ijoa.2021.103207_b0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3348\/kjr.2018.19.4.585","article-title":"Recent update of embolization of postpartum hemorrhage","volume":"19","author":"Chen","year":"2018","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.ijoa.2021.103207_b0465","article-title":"Postpartum hemorrhage with uterine artery embolization: the risk of complications of uterine artery embolization","volume":"1\u20138","author":"Kim","year":"2020","journal-title":"Minim Invasive Ther Allied Technol"}],"container-title":["International Journal of Obstetric Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X2100265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X2100265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:03:14Z","timestamp":1760698994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959289X2100265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":93,"alternative-id":["S0959289X2100265X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijoa.2021.103207","relation":{},"ISSN":["0959-289X"],"issn-type":[{"value":"0959-289X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory uterine atony: still a problem after all these years","name":"articletitle","label":"Article Title"},{"value":"International Journal of Obstetric Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijoa.2021.103207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103207"}}